SEngine Precision Medicine to Present Data Related to the Predictive Value of PARIS® Test, an Organoid-based Drug Response Assay, for Cholangiocarcinoma Patients at 2020 AACR Virtual Meeting Session II
15 mai 2020 12h52 HE
|
SEngine Precision Medicine
SEATTLE, May 15, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on...
SEngine Precision Medicine to Present Data Related to the Predictive Value of the PARIS® Test for Oncology Drugs Based on Retrospective Analysis at 2020 ASCO Annual Meeting
13 mai 2020 17h18 HE
|
SEngine Precision Medicine
SEATTLE, May 13, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on...
SEngine Precision Medicine Names Surgical Oncologist and Cancer Care Advocate Dr. Astrid Margossian as Chief Medical Officer
14 nov. 2019 09h08 HE
|
SEngine Precision Medicine
SEATTLE, Washington, Nov. 14, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its proprietary diagnostic platform known as The...
SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform
02 oct. 2019 09h00 HE
|
SEngine Precision Medicine
SEATTLE, Wash., Oct. 02, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its CLIA certified, proprietary diagnostic platform...
SEngine Precision Medicine Announces Experienced Technology Executive Tom Neary as Chief Financial Officer
20 août 2019 08h50 HE
|
SEngine Precision Medicine
SEATTLE, Washington, Aug. 20, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its proprietary diagnostic tool known as the PARIS...
SEngine Precision Medicine Announces Renowned Medicinal Chemist to Join Scientific Advisory Board
25 avr. 2019 09h15 HE
|
SEngine Precision Medicine
SEATTLE, April 25, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology startup accelerating cancer drug discovery through its proprietary diagnostic tool known as the PARIS Test®, today...
SEngine Precision Medicine Announces Pulitzer Prize Winner and Pioneering Oncologist Dr. Siddhartha Mukherjee to Join Scientific Advisory Board
05 févr. 2019 08h15 HE
|
SEngine Precision Medicine
SEATTLE, Feb. 05, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a biotech startup redefining how cancer is managed and accelerating life-saving discoveries through the promise of precision...
SEngine Precision Medicine Announces Nobel Prize Winner and Former Fred Hutch Cancer Research Center President Dr. Leland Hartwell to Join Board of Directors
29 oct. 2018 10h15 HE
|
SEngine Precision Medicine
SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a biotech startup delivering on the promise of precision oncology through functional genomics, today welcomed Dr. Leland (Lee)...